QL1207

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QL1207, covering 2022-04-25 to 2022-04-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare QL1207 to Eylea® in Subjects With Wet Age-related Macular Degeneration (wAMD) [Phase 3]